Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials

Preclinical studies have shown that neurotrophic growth factors (NTFs) extend the survival of motor neurons in amyotrophic lateral sclerosis (ALS) and that the combined delivery of these neurotrophic factors has a strong synergistic effect. We have developed a culture-based method for inducing mesen...

Full description

Bibliographic Details

Published in:	JAMA neurology Vol. 73; no. 3; p. 337
Main Authors:	Petrou, Panayiota, Gothelf, Yael, Argov, Zohar, Gotkine, Marc, Levy, Yossef S, Kassis, Ibrahim, Vaknin-Dembinsky, Adi, Ben-Hur, Tamir, Offen, Daniel, Abramsky, Oded, Melamed, Eldad, Karussis, Dimitrios
Format:	Journal Article
Language:	English
Published:	United States 01.03.2016
Subjects:	Adult Aged Amyotrophic Lateral Sclerosis - therapy Female Follow-Up Studies Humans Male Mesenchymal Stem Cell Transplantation - adverse effects Mesenchymal Stem Cell Transplantation - methods Mesenchymal Stromal Cells - secretion Middle Aged Nerve Growth Factors - secretion Outcome Assessment (Health Care) Transplantation, Autologous Young Adult
ISSN:	2168-6157, 2168-6157
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!